
Established in 1995, Mankind Pharma Limited is a big player in making medicines and healthcare products. They create and sell medicines for different health problems, both common and serious. This industry is super important, not just in India but all around the world. In India, medicine companies like Mankind Pharma are crucial for keeping people healthy and boosting the country’s economy. Globally, these companies help millions of people by making and providing essential medicines.
Now, when we talk about Mankind Pharma aiming for a price target of 10k, it’s not just about numbers. It’s about their hard work and dedication to making good medicines accessible to everyone. It’s like setting a big goal to keep doing better and helping more people stay healthy.
About Mankind Pharma
Recent News Around Mankind Pharma
Mankind Pharma Q3 Fy2024 Key Points And Summary:
Mankind Pharma Share Price Target 2024 To 2030
Mankind Pharma Share Price Target 2024
Month | Maximum Price (₹) | Minimum Price (₹) |
---|---|---|
April 2024 | ₹2,378.19 | ₹2,067.99 |
May 2024 | ₹2,343.05 | ₹2,037.43 |
June 2024 | ₹2,427.40 | ₹2,110.78 |
July 2024 | ₹2,403.12 | ₹2,089.67 |
August 2024 | ₹2,499.25 | ₹2,173.26 |
September 2024 | ₹2,599.22 | ₹2,260.19 |
October 2024 | ₹2,548.25 | ₹2,215.87 |
November 2024 | ₹2,624.70 | ₹2,282.35 |
December 2024 | ₹2,690.32 | ₹2,339.40 |
Mankind Pharma Share Price Target 2025
when | Maximum Price | Minimum Price |
January 2025 | ₹2,744.12 | ₹2,110.86 |
February 2025 | ₹2,814.48 | ₹2,164.99 |
March 2025 | ₹2,924.25 | ₹2,249.42 |
April 2025 | ₹2,866.91 | ₹2,205.32 |
May 2025 | ₹2,783.41 | ₹2,141.08 |
June 2025 | ₹2,908.66 | ₹2,237.43 |
July 2025 | ₹2,851.63 | ₹2,193.56 |
August 2025 | ₹2,939.82 | ₹2,261.40 |
September 2025 | ₹3,042.72 | ₹2,340.55 |
October 2025 | ₹3,121.83 | ₹2,401.41 |
November 2025 | ₹3,199.87 | ₹2,461.44 |
December 2025 | ₹3,279.87 | ₹2,522.98 |
In 2025, Mankind Pharma’s share price is expected to continue its upward trend, reflecting positive market sentiment and the company’s performance. The maximum price is projected to steadily increase, reaching ₹3,279.87 in December, while the minimum price is anticipated to follow a similar trajectory, reaching ₹2,522.98 in the same month. These expected prices indicate potential growth opportunities for investors, driven by factors such as product innovation, market expansion, and strong financial performance. Investors can monitor key events and market dynamics to make informed decisions regarding their investment in Mankind Pharma.
Mankind Pharma Share Price Target 2026 To 2030
Mankind Pharma’s Financial Condition (Last 5 Years)
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
Sales + | 3,829 | 4,794 | 5,523 | 7,486 | 8,127 | 8,984 |
Expenses + | 3,124 | 3,550 | 4,151 | 5,644 | 6,429 | 6,825 |
Operating Profit | 705 | 1,244 | 1,372 | 1,842 | 1,698 | 2,159 |
OPM % | 18% | 26% | 25% | 25% | 21% | 24% |
Other Income + | 64 | 94 | 154 | 200 | 163 | 225 |
Interest | 40 | 11 | 8 | 48 | 28 | 11 |
Depreciation | 38 | 62 | 78 | 123 | 270 | 303 |
Profit before tax | 691 | 1,265 | 1,440 | 1,871 | 1,563 | 2,070 |
Tax % | 26% | 24% | 25% | 26% | 20% | |
Net Profit + | 514 | 958 | 1,084 | 1,389 | 1,248 | 1,650 |
EPS in Rs | 12.83 | 23.92 | 27.07 | 34.68 | 31.16 | 41.19 |
Dividend Payout % | 0% | 32% | 0% | 0% | 0% |
Leave a Reply